Literature DB >> 23138551

[Update on granulomatosis with polyangitis (GPA, Wegener's granulomatosis)].

J U Holle1, E Reinhold-Keller, W L Gross.   

Abstract

Granulomatosis with polyangitis (GPA, Wegener's granulomatosis) is characterized by a granulomatous inflammation of the respiratory tract and a necrotizing ANCA-associated small to medium-size vessel vasculitis with a predilection for the lungs (pulmonary capillaritis) and kidneys (necrotizing glomerulonephritis). The disease evolves stage-wise and typically starts as inflammation of the respiratory tract followed by development of systemic vasculitis manifestations. Today, treatment is evidence-based and adapted according to activity and disease stage which has resulted in a significant improvement in long-term outcome. Early mortality during the first year of treatment poses one of the main problems and is a result of infections under immunosuppressive treatment. Furthermore, treatment of refractory disease activity which is often represented by granulomatous manifestations is still a challenge and may result in significant organ damage if not treated successfully.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138551     DOI: 10.1007/s00393-012-0982-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  35 in total

1.  Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Michael Walsh; Oliver Flossmann; Annelies Berden; Kerstin Westman; Peter Höglund; Coen Stegeman; David Jayne
Journal:  Arthritis Rheum       Date:  2012-02

2.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Rachel B Jones; Alastair J Ferraro; Afzal N Chaudhry; Paul Brogan; Alan D Salama; Kenneth G C Smith; Caroline O S Savage; David R W Jayne
Journal:  Arthritis Rheum       Date:  2009-07

4.  Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Authors:  D R Jayne; H Chapel; D Adu; S Misbah; D O'Donoghue; D Scott; C M Lockwood
Journal:  QJM       Date:  2000-07

5.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.

Authors:  K W Westman; P G Bygren; H Olsson; J Ranstam; J Wieslander
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

6.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

Authors:  Shouichi Fujimoto; Richard A Watts; Shigeto Kobayashi; Kazuo Suzuki; David R W Jayne; David G I Scott; Hiroshi Hashimoto; Hiroyuki Nunoi
Journal:  Rheumatology (Oxford)       Date:  2011-07-28       Impact factor: 7.580

7.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

8.  Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.

Authors:  P Eriksson; L Jacobsson; A Lindell; J-A Nilsson; T Skogh
Journal:  J Intern Med       Date:  2008-12-23       Impact factor: 8.989

9.  Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.

Authors:  Renate Kain; Markus Exner; Ricarda Brandes; Reinhard Ziebermayr; Dawn Cunningham; Carol A Alderson; Agnes Davidovits; Ingrid Raab; Renate Jahn; Oliver Ashour; Susanne Spitzauer; Gere Sunder-Plassmann; Minoru Fukuda; Per Klemm; Andrew J Rees; Dontscho Kerjaschki
Journal:  Nat Med       Date:  2008-10-05       Impact factor: 53.440

10.  A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.

Authors:  Eoin F McKinney; Paul A Lyons; Edward J Carr; Jane L Hollis; David R W Jayne; Lisa C Willcocks; Maria Koukoulaki; Alvis Brazma; Vojislav Jovanovic; D Michael Kemeny; Andrew J Pollard; Paul A Macary; Afzal N Chaudhry; Kenneth G C Smith
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

View more
  2 in total

1.  [Recommendations on the use of rituximab for ANCA-associated vasculitis].

Authors:  A M Gause; A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

2.  [Otitis media with acute progressive lung failure?]

Authors:  U Ziehn; B Wollschläger; B Schmidt
Journal:  Pneumologe (Berl)       Date:  2014-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.